Journal of Peking University(Health Sciences) >
Effects of circular RNA circ-SOD2 on intestinal epithelial barrier and ulcerative colitis
Received date: 2019-01-02
Online published: 2019-10-23
Supported by
Supported by the Peking University People’s Hospital Research and Development Funds Project(RDX2018-05)
Objective: To explore the expression profiling of circRNAs in ulcerative colitis(UC) and then determine the significantly changed circRNA and its influences on intestinal epithelial barrier. Methods: In this study, we selected 5 pairs of inflamed and normal colorectal mucosa tissues from UC patients to perform circRNAs microarray and identified the differentially expressed circRNAs in the UC inflamed colorectal mucosa tissues, and quantitative real-time PCR was used to identify the expression change of circ-SOD2 in 30 UC patients’ inflamed and normal colorectal mucosa tissues. We detected the expression of circ-SOD2 in Caco2 and NCM460 cells after being treated with inflammatory factors (LPS, TNF-α, IL1-β). Fluorescence in situ hybridization (FISH) was used to determine the cellular location of circ-SOD2 in the UC colorectal mucosal tissues. The circ-SOD2 overexpression vector was constructed and produced and then transfected into Caco2 cells to examine the cells’ trans-epithelial electrical resistance (TEER), permeability of FITC-dextran and the alterations of epithelial barrier related molecules. Results: We found 264 circRNAs (111 increased and 153 decreased) differentially expressed in the inflamed colon mucosa compared with normal colon mucosa using a P-value <0.05 and a >1.5-fold change cutoff. To validate the circRNA microarray results, we selected some circRNAs to perform qRT-PCR based on the following criteria: (1)circRNAs raw data >100 in each sample, (2)fold-change >2, (3)P<0.05. We identified 10 dysregulated circRNA, among them, circ-SOD2 was upregulated with maximum fold-change in the UC inflamed colorectal mucosa tissues. Then we identified circ-SOD2 was upregulated significantly through quantitative real-time PCR (qRT-PCR) in expanded 30 paired colorectal mucosa tissues(P<0.001). After treatments with LPS, TNF-α and IL1-β, circ-SOD2 was upregulated in Caco2 and NCM460 cells at different points from 1 to 7 h. Fluorescence in situ hybridization (FISH) indicated that circ-SOD2 located in intestinal epithelium mostly and few in mesenchyme and inflammatory cells. The overexpression of circ-SOD2 in Caco2 cells resulted in a decrease of transepithelial electrical resistance (TEER), an increase of the FITC-dextran permeability and the downregulation of epithelial barrier related molecule CLDN-8 (P<0.05). Conclusion: The dysregulation of circRNAs existed in UC inflamed colorectal mucosa, among which, the upregulated circ-SOD2 weakened the intestinal epithelial barrier and thus might promote the occurrence of ulcerative colitis.
Key words: circRNAs; circ-SOD2; Intestinal epithelial barrier; Ulcerative colitis
Ting-ting WANG , Ying HAN , Fang-fang GAO , Lei YE , Yu-jun ZHANG . Effects of circular RNA circ-SOD2 on intestinal epithelial barrier and ulcerative colitis[J]. Journal of Peking University(Health Sciences), 2019 , 51(5) : 805 -812 . DOI: 10.19723/j.issn.1671-167X.2019.05.003
| [1] | Magro FGP, Eliakim R, Ardizzone S , et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders[J]. J Crohns Colitis, 2017,11(6):649-670. |
| [2] | Ng SC, Shi HY, Hamidi N , et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J]. Lancet, 2017,390(10114):2769-2778. |
| [3] | Costello CM, Mah N, Hasler R , et al. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays[J]. PLoS Med, 2005,2(8):e199. |
| [4] | Ventham NT, Kennedy NA, Nimmo ER , et al. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics[J]. Gastroenterology, 2013,145(2):293-308. |
| [5] | Jeck WR, Sorrentino JA, Wang K , et al. Circular RNAs are abundant, conserved, and associated with ALU repeats[J]. RNA, 2013,19(2):141-157. |
| [6] | Salzman J, Chen RE, Olsen MN , et al. Cell-type specifc features of circular RNA expression[J]. PLoS Genet, 2013,9(9):e1003777. |
| [7] | Han D, Li J, Wang H , et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression[J]. Hepatology, 2017,66(4):1151-1164. |
| [8] | Guarnerio J, Bezzi M, Jeong JC , et al. Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations[J]. Cell, 2016,165(2):289-302. |
| [9] | Liu Q, Zhang X, Hu X , et al. Circular RNA related to the chondrocyte ECM regulates MMP13 expression by functioning as a MiR-136 ‘Sponge’ in human cartilage degradation[J]. Sci Rep, 2016,6:22572. |
| [10] | Iparraguirre L, Munoz-Culla M, Prada-Luengo I , et al. Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis[J]. Hum Mol Genet, 2017,26(18):3564-3572. |
| [11] | Qiao YQ, Cai CW, Shen J , et al. Circular RNA expression alterations in colon tissues of Crohn’s disease patients[J]. Mol Med Rep, 2019,19(5):4500-4506. |
| [12] | Yuan G, Chen T, Zhang H , et al. Comprehensive analysis of differential circular RNA expression in a mouse model of colitis-induced colon carcinoma[J]. Mol Carcinog, 2018,57(12):1825-1834. |
| [13] | Piwecka M, Glazar P, Hernandez-Miranda LR , et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function[J]. Science, 2017,357(6357):8526. |
| [14] | Min M, Peng L, Yang Y , et al. MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a[J]. Inflamm Bowel Dis, 2014,20(4):652-659. |
| [15] | Wang H, Chao K, Ng SC , et al. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease[J]. Genome Biol, 2016,17:58. |
| [16] | He C, Yu T, Shi Y , et al. MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhi-biting BTG1[J]. Gastroenterology, 2017,152(6):1434-1448. |
| [17] | Qu S, Yang X, Li X , et al. Circular RNA: a new star of non-coding RNAs[J]. Cancer Lett, 2015,365(2):141-148. |
| [18] | Gla?ar P, Papavasileiou P, Rajewsky N . circBase: a database for circular RNAs[J]. RNA, 2014,20(11):1666-1670. |
| [19] | Kramer MC, Liang D, Tatomer DC , et al. Combinatorial control of drosophila circular RNA expression by intronic repeats, hnRNPs, and SR proteins[J]. Genes Dev, 2015,29(20):2168-2182. |
| [20] | Gerasimenko TN, Senyavina NV, Anisimov NU , et al. A model of cadmium uptake and transport in Caco-2 cells[J]. Bull Exp Biol Med, 2016,161(1):187-192. |
| [21] | Mirza AH, Berthelsen CH, Seemann SE , et al. Transcriptomic landscape of lncRNAs in inflammatory bowel disease[J]. Genome Med, 2015,7(1):39. |
| [22] | Wu F, Huang Y, Dong F , et al. Ulcerative colitis-associated long noncoding RNA, BC012900, regulates intestinal epithelial cell apoptosis[J]. Inflamm Bowel Dis, 2016,22(4):782-795. |
| [23] | Hammond SM . An overview of microRNAs[J]. Adv Drug Deliv Rev, 2015,87:3-14. |
/
| 〈 |
|
〉 |